awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q48216426-DD828189-DCC8-4DEF-A144-B336ACE9D1A3
Q48216426-DD828189-DCC8-4DEF-A144-B336ACE9D1A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48216426-DD828189-DCC8-4DEF-A144-B336ACE9D1A3
Interchangeability of biosimilar and biological reference product: updated regulatory positions and pre- and post-marketing evidence.
P2860
Q48216426-DD828189-DCC8-4DEF-A144-B336ACE9D1A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48216426-DD828189-DCC8-4DEF-A144-B336ACE9D1A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8ae3936e091c7842425a9ce799acabc5c4925e73
P2860
A review of the literature analyzing benefits and concerns of infliximab biosimilar CT-P13 for the treatment of rheumatologic diseases: focus on interchangeability.